Detalles de la búsqueda
1.
Liraglutide and not lifestyle intervention reduces soluble CD163 after comparable weight loss in obese participants with prediabetes or type 2 diabetes mellitus.
Cardiovasc Diabetol;
23(1): 146, 2024 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38685051
2.
IDegLira for the real-world treatment of type 2 diabetes in Italy. Final results from the REX observational study.
Diabetes Obes Metab;
26(5): 1746-1756, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38327240
3.
Oral or injectable semaglutide for the management of type 2 diabetes in routine care: A multicentre observational study comparing matched cohorts.
Diabetes Obes Metab;
26(6): 2390-2400, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38477183
4.
Continuous glucose monitoring (CGM) in a non-Icu hospital setting: The patient's journey.
Nutr Metab Cardiovasc Dis;
33(11): 2107-2118, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37574433
5.
LDL-cholesterol control in the primary prevention of cardiovascular diseases: An expert opinion for clinicians and health professionals.
Nutr Metab Cardiovasc Dis;
33(2): 245-257, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36566123
6.
Semaglutide reduces cardiovascular events regardless of metformin use: a post hoc subgroup analysis of SUSTAIN 6 and PIONEER 6.
Cardiovasc Diabetol;
21(1): 64, 2022 04 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35484580
7.
Effects of liraglutide vs. lifestyle changes on soluble suppression of tumorigenesis-2 (sST2) and galectin-3 in obese subjects with prediabetes or type 2 diabetes after comparable weight loss.
Cardiovasc Diabetol;
21(1): 36, 2022 03 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35277168
8.
Health care organization and use of technological devices in people with diabetes in Italy: Results from a survey of the Working Group on Diabetes and Technology.
Nutr Metab Cardiovasc Dis;
32(10): 2392-2398, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35970683
9.
Comparative effectiveness of dapagliflozin vs DPP-4 inhibitors on a composite endpoint of HbA1c, body weight and blood pressure reduction in the real world.
Diabetes Metab Res Rev;
37(1): e3353, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32453482
10.
Beneficial effects of glucagon-like peptide 1 receptor agonists on glucose control, cardiovascular risk profile, and non-alcoholic fatty liver disease. An expert opinion of the Italian diabetes society.
Nutr Metab Cardiovasc Dis;
31(12): 3257-3270, 2021 11 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34627692
11.
Consensus report of the joint workshop of the Italian Society of Diabetology, Italian Society of Periodontology and Implantology, Italian Association of Clinical Diabetologists (SID-SIdP-AMD).
Nutr Metab Cardiovasc Dis;
31(9): 2515-2525, 2021 08 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-34238654
12.
Insulin resistance and NAFLD may influence memory performance in obese patients with prediabetes or newly-diagnosed type 2 diabetes.
Nutr Metab Cardiovasc Dis;
31(9): 2685-2692, 2021 08 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-34226120
13.
Cardiovascular risk management in type 2 diabetes mellitus: A joint position paper of the Italian Cardiology (SIC) and Italian Diabetes (SID) Societies.
Nutr Metab Cardiovasc Dis;
31(6): 1671-1690, 2021 06 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33994263
14.
Liraglutide improves memory in obese patients with prediabetes or early type 2 diabetes: a randomized, controlled study.
Int J Obes (Lond);
44(6): 1254-1263, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31965072
15.
In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance.
Diabetes Metab Res Rev;
36(2): e3232, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31671234
16.
Enrolment criteria for diabetes cardiovascular outcome trials do not inform on generalizability to clinical practice: The case of glucagon-like peptide-1 receptor agonists.
Diabetes Obes Metab;
22(5): 817-827, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31943710
17.
Positioning sulphonylureas in a modern treatment algorithm for patients with type 2 diabetes: Expert opinion from a European consensus panel.
Diabetes Obes Metab;
22(10): 1705-1713, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32476244
18.
Management of type 2 diabetes for prevention of cardiovascular disease. An expert opinion of the Italian Diabetes Society.
Nutr Metab Cardiovasc Dis;
30(11): 1926-1936, 2020 10 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-32928628
19.
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
N Engl J Med;
375(19): 1834-1844, 2016 11 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27633186
20.
Glucagon-like peptide-1 receptor agonists in type 2 diabetes treatment: are they all the same?
Diabetes Metab Res Rev;
35(1): e3070, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30156747